Literature DB >> 8837911

Testing the effect of season of birth on familial risk for schizophrenia and related disorders.

J M Hettema1, D Walsh, K S Kendler.   

Abstract

BACKGROUND: An excess of late winter and early spring births in schizophrenia has been repeatedly demonstrated. Previous evidence has suggested that the risk for schizophrenia may differ in relatives of schizophrenic probands born in this high risk period v. at other times of the year.
METHOD: In an epidemiologically based family study conducted in the west of Ireland, we examined the relationship between season of birth in schizophrenia and schizophrenia spectrum probands and the risk for schizophrenia and related disorders in first-degree relatives. Risk was assessed using the Cox proportional hazard method. We examined four birth seasons previously shown to significantly predict risk for schizophrenia.
RESULTS: Neither the risk for schizophrenia nor that for schizophrenia spectrum disorders in relatives was significantly associated with season of birth in probands.
CONCLUSIONS: Season of birth does not, in this sample, identify schizophrenic probands with particularly high or low familial vulnerability to illness.

Entities:  

Mesh:

Year:  1996        PMID: 8837911     DOI: 10.1192/bjp.168.2.205

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

1.  Familial aggregation of schizophrenia: the moderating effect of age at onset, parental immigration, paternal age and season of birth.

Authors:  Anna C Svensson; Paul Lichtenstein; Sven Sandin; Sara Öberg; Patrick F Sullivan; Christina M Hultman
Journal:  Scand J Public Health       Date:  2011-09-19       Impact factor: 3.021

2.  Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort.

Authors:  Valentina Escott-Price; Daniel J Smith; Kimberley Kendall; Joey Ward; George Kirov; Michael J Owen; James Walters; Michael C O'Donovan
Journal:  Psychol Med       Date:  2018-03-04       Impact factor: 7.723

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.